Barbara Vitolo
Pavia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Serum calprotectin as a marker of ultrasound-detected synovitis in early psoriatic and rheumatoid arthritis: results from a cross-sectional retrospective study.
Journal: Clinical and experimental rheumatology
Published: May 09, 2018
Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors.
Journal: Arthritis research & therapy
Published: July 30, 2016
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis.
Journal: Arthritis research & therapy
Published: July 12, 2016
Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: December 15, 2014
The draining lymph node in rheumatoid arthritis: current concepts and research perspectives.
Journal: BioMed research international
Published: July 01, 2014
High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease.
Journal: Rheumatology (Oxford, England)
Published: April 26, 2014
B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers.
Journal: BioMed research international
Published: January 12, 2014
Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs.
Journal: Arthritis research & therapy
Published: November 07, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026